WCN26-4831 Association between Corticosteroid Therapy and Adverse Events in Patients with IgA Nephropathy: A Post Hoc Analysis of Two Nationwide Japanese Cohort Studies

Read full text Summarise with VIRAT
Authors: Kento Kitamura, Masahiro Okabe, Takaya Sasaki, Akihiro Shimizu, Kentaro Koike, Hiroyuki Ueda, Nobuo Tsuboi, Tetsuya Kawamura, Yusuke Suzuki, Takashi Yokoo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Corticosteroids are widely used in IgA nephropathy (IgAN) for their renoprotective effects, yet concerns remain about their long-term safety. The influence of baseline characteristics on steroid-related adverse events is unclear, and it is uncertain whether delaying progression to end-stage kidney disease reduces systemic complications. Two recent nationwide Japanese cohort studies (JNR-IgAN 2019 and J-IGACS 2023) showed slower renal decline with corticosteroid use. This study aimed to evaluate the association between corticosteroid therapy and systemic adverse outcomes in patients with IgAN.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104796–104796
Publication date
25 March 2026
Language
EN